| |
| |
|
| Insider
Information: |
Foletta Mark G |
| Relationship: |
EVP & Chief Financial ... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
110,179 |
|
|
Indirect Shares
|
62,398 |
|
|
| Direct
Value |
$1,139,767 |
|
|
|
Indirect Value
|
$7,947,633 |
|
|
| Total
Shares |
172,577 |
|
|
| Total
Value |
$9,087,400 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
| Percentage
Gain/Loss : |
 0.7%
|
13.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
SVP, Chief Financial O... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
DexCom Inc |
DXCM |
Director |
2024-05-22 |
2,973 |
2024-05-22 |
62,398 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2017-12-04 |
81,910 |
2015-08-13 |
0 |
Premium* |
|
|
AMN Healthcare Services Inc |
AHS |
Director |
2024-04-19 |
10,254 |
2016-04-20 |
0 |
Premium* |
|
|
Forte Biosciences Inc |
FBRX |
EVP & Chief Financial ... |
2019-05-28 |
15,042 |
2017-04-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
144 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
• – – |
2007-03-30 |
4 |
AS |
$37.61 |
$94,025 |
D/D |
(2,500) |
23,242 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
• – – |
2007-03-30 |
4 |
OE |
$13.25 |
$33,125 |
D/D |
2,500 |
25,742 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
• – – |
2007-04-30 |
4 |
OE |
$13.25 |
$33,125 |
D/D |
2,500 |
25,742 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
• – – |
2007-04-30 |
4 |
AS |
$42.32 |
$105,800 |
D/D |
(2,500) |
23,242 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
• – – |
2007-06-29 |
4 |
OE |
$13.25 |
$33,125 |
D/D |
2,500 |
25,742 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
• – – |
2007-06-29 |
4 |
AS |
$41.38 |
$103,455 |
D/D |
(2,500) |
23,242 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2017-11-27 |
4 |
S |
$54.95 |
$137,386 |
I/I |
(2,500) |
13,143 |
0 |
- |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2017-11-27 |
4 |
S |
$47.03 |
$117,575 |
D/D |
(2,500) |
3,525 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
EVP & Chief Financial Officer |
• – – |
2017-12-08 |
4 |
A |
$8.50 |
$21,250 |
D/D |
2,500 |
7,500 |
0 |
- |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2021-06-11 |
4 |
S |
$95.02 |
$237,540 |
D/D |
(2,500) |
12,276 |
0 |
% |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Finance & CFO |
• – – |
2009-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
2,550 |
3,455 |
0 |
- |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2021-04-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,826 |
14,776 |
0 |
- |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2020-04-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,907 |
11,950 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP & Chief Financial Officer |
• – – |
2004-09-02 |
4 |
OE |
$5.73 |
$26,256 |
D/D |
2,930 |
19,429 |
|
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2024-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,973 |
2,973 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
• – – |
2004-10-29 |
4 |
OE |
$5.73 |
$17,190 |
D/D |
3,000 |
22,262 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
• – – |
2004-10-29 |
4 |
AS |
$21.05 |
$63,143 |
D/D |
(3,000) |
19,262 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
• – – |
2004-11-30 |
4 |
OE |
$5.73 |
$17,190 |
D/D |
3,000 |
22,262 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
• – – |
2004-11-30 |
4 |
AS |
$20.35 |
$61,050 |
D/D |
(3,000) |
19,262 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
• – – |
2004-12-31 |
4 |
OE |
$5.73 |
$17,190 |
D/D |
3,000 |
22,262 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP Finance & CFO |
• – – |
2004-12-31 |
4 |
AS |
$23.50 |
$70,500 |
D/D |
(3,000) |
19,262 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
• – – |
2007-08-31 |
4 |
OE |
$13.25 |
$39,750 |
D/D |
3,000 |
26,242 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
• – – |
2007-08-31 |
4 |
AS |
$48.86 |
$146,575 |
D/D |
(3,000) |
23,242 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
• – – |
2007-09-28 |
4 |
OE |
$13.25 |
$39,750 |
D/D |
3,000 |
26,242 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Senior VP, Finance & CFO |
• – – |
2007-09-28 |
4 |
AS |
$49.98 |
$149,932 |
D/D |
(3,000) |
23,242 |
0 |
- |
|
144 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
